Ascendis Pharma A/S (NASDAQ:ASND) Stake Reduced by Rhumbline Advisers
Rhumbline Advisers reduced its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 6.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,460 shares of the biotechnology company’s stock after selling 108 shares during the quarter. […]
Rhumbline Advisers reduced its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 6.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,460 shares of the biotechnology company’s stock after selling 108 shares during the quarter. […]
